Isracann Biosciences Stock Market Value
Isracann Biosciences' market value is the price at which a share of Isracann Biosciences trades on a public exchange. It measures the collective expectations of Isracann Biosciences investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of Isracann Biosciences and determine expected loss or profit from investing in Isracann Biosciences over a given investment horizon. Check out Isracann Biosciences Correlation, Isracann Biosciences Volatility and Isracann Biosciences Performance module to complement your research on Isracann Biosciences.
| Symbol | Isracann |
Isracann Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Isracann Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Isracann Biosciences.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Isracann Biosciences on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Isracann Biosciences or generate 0.0% return on investment in Isracann Biosciences over 90 days. Isracann Biosciences is related to or competes with Raphael Pharmaceutical, Avicanna, Voyageur Pharmaceuticals, and Charlottes Web. Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel More
Isracann Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Isracann Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Isracann Biosciences upside and downside potential and time the market with a certain degree of confidence.
Isracann Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Isracann Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Isracann Biosciences' standard deviation. In reality, there are many statistical measures that can use Isracann Biosciences historical prices to predict the future Isracann Biosciences' volatility.Isracann Biosciences Backtested Returns
We have found zero technical indicators for Isracann Biosciences, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Isracann Biosciences are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Isracann Biosciences has no correlation between past and present. Overlapping area represents the amount of predictability between Isracann Biosciences time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Isracann Biosciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current Isracann Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Isracann Pink Sheet
Isracann Biosciences financial ratios help investors to determine whether Isracann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isracann with respect to the benefits of owning Isracann Biosciences security.